Consistent with our published studies [23], p66ShcA increases Vimentin expression in ErbB2+ luminal breast tumors (NIC) whereas E-Cadherin levels are largely unaffected compared to control tumors (Additional file 7: Figure S7). The gene discussed is VIM; the disease is breast neoplasm.